A detailed history of Prudential Financial Inc transactions in Applied Therapeutics Inc. stock. As of the latest transaction made, Prudential Financial Inc holds 11,280 shares of APLT stock, worth $104,678. This represents 0.0% of its overall portfolio holdings.

Number of Shares
11,280
Holding current value
$104,678
% of portfolio
0.0%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 13, 2024

BUY
$4.35 - $8.5 $49,067 - $95,880
11,280 New
11,280 $95,000
Q1 2024

May 14, 2024

BUY
$2.25 - $7.4 $25,425 - $83,620
11,300 New
11,300 $76,000

Others Institutions Holding APLT

About Applied Therapeutics Inc.


  • Ticker APLT
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 48,020,700
  • Market Cap $446M
  • Description
  • Applied Therapeutics, Inc., a clinical-stage biopharmaceutical company, develops novel products to target cardiovascular disease, galactosemia, and diabetic complications. Its lead product candidate is AT-007 that has completed phase 1/2 for the treatment of galactosemia in healthy volunteers and adults, as well as is in pediatric clinical study...
More about APLT
Track This Portfolio

Track Prudential Financial Inc Portfolio

Follow Prudential Financial Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Prudential Financial Inc, based on Form 13F filings with the SEC.

News

Stay updated on Prudential Financial Inc with notifications on news.